Didik Steven, Golosova Daria, Zietara Adrian, Bohovyk Ruslan, Ahrari Ameneh, Levchenko Vladislav, Kravtsova Olha, Taneja Krish, Khedr Sherif, Semenikhina Marharyta, Palygin Oleg, Staruschenko Alexander
Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 33602, USA.
James A. Haley Veterans Hospital, Tampa, FL 33612, USA.
Function (Oxf). 2025 Aug 1;6(4). doi: 10.1093/function/zqaf028.
Opioid use for pain management and illicit consumption has been associated with adverse cardiovascular and cardiorenal outcomes. Despite these associations, the mechanisms underlying opioid-induced kidney damage remain poorly understood. Recently, we demonstrated that stimulation of kappa opioid receptors (KOR) is implicated in the aggravation of salt-sensitive hypertension, glomerular injury, and podocyte damage through excessive podocyte calcium influx. This study aims to elucidate the KOR signaling and renal outcomes underlying opioid use in Sprague-Dawley (SD) rats. Here, we employed freshly isolated glomeruli from SD male rats and immortalized human podocyte cell cultures to investigate the role of KORs in podocyte calcium regulation and overall glomerular function. A glomerular permeability assay was used to evaluate the impact of KORs on glomerular filter integrity. Additionally, the long-term effects of KOR activation were assessed in vivo by chronic intravenous infusion of selective KOR agonist BRL 52537 in SD rats. We found that acute application of BRL 52537 resulted in increased plasma membrane ion channel activity in immortalized human podocytes. Significant calcium influx in response to BRL 52537 was detected in podocytes of the isolated SD rat glomeruli. Further, glomerular permeability analysis revealed increased permeability and impaired filter integrity, indicating altered glomerular function. Lastly, prolonged KOR activation in SD rats results in an increase in blood pressure, an elevation of basal calcium levels in podocytes, and albuminuria. In conclusion, this study identifies novel renal physiological mechanisms through which opioid-induced KOR activation contributes to podocyte injury and glomerular damage in SD rats.
用于疼痛管理的阿片类药物使用及非法消费与不良心血管和心肾结局相关。尽管存在这些关联,但阿片类药物所致肾损伤的潜在机制仍知之甚少。最近,我们证明κ阿片受体(KOR)的刺激通过足细胞钙过度内流参与盐敏感性高血压、肾小球损伤和足细胞损伤的加重。本研究旨在阐明Sprague-Dawley(SD)大鼠中阿片类药物使用所涉及的KOR信号传导及肾脏结局。在此,我们使用从SD雄性大鼠新鲜分离的肾小球和永生化人足细胞培养物来研究KOR在足细胞钙调节和整体肾小球功能中的作用。采用肾小球通透性测定法评估KOR对肾小球滤过完整性的影响。此外,通过在SD大鼠中慢性静脉输注选择性KOR激动剂BRL 52537在体内评估KOR激活的长期影响。我们发现急性应用BRL 52537导致永生化人足细胞的质膜离子通道活性增加。在分离的SD大鼠肾小球的足细胞中检测到对BRL 52537有显著的钙内流。此外,肾小球通透性分析显示通透性增加和滤过完整性受损,表明肾小球功能改变。最后,SD大鼠中KOR的长期激活导致血压升高、足细胞基础钙水平升高和蛋白尿。总之,本研究确定了新的肾脏生理机制,通过这些机制阿片类药物诱导的KOR激活导致SD大鼠足细胞损伤和肾小球损伤。